Literature DB >> 33392919

Expression of NLRP3 Inflammasomes in Neurogenic Niche Contributes to the Effect of Spatial Learning in Physiological Conditions but Not in Alzheimer's Type Neurodegeneration.

Yulia K Komleva1,2, O L Lopatina3,4, Ya V Gorina3,4, A I Chernykh4, L V Trufanova3, E F Vais3, E V Kharitonova3, E L Zhukov5, L Yu Vahtina6, N N Medvedeva6, A B Salmina3,4.   

Abstract

A common feature of neurodegenerative disorders, in particular Alzheimer's disease (AD), is a chronic neuroinflammation associated with aberrant neuroplasticity. Development of neuroinflammation affects efficacy of stem and progenitor cells proliferation, differentiation, migration, and integration of newborn cells into neural circuitry. However, precise mechanisms of neurogenesis alterations in neuroinflammation are not clear yet. It is well established that expression of NLRP3 inflammasomes in glial cells marks neuroinflammatory events, but less is known about contribution of NLRP3 to deregulation of neurogenesis within neurogenic niches and whether neural stem cells (NSCs), neural progenitor cells (NPCs) or immature neuroblasts may express inflammasomes in (patho)physiological conditions. Thus, we studied alterations of neurogenesis in rats with the AD model (intra-hippocampal injection of Aβ1-42). We found that in Aβ-affected brain, number of CD133+ cells was elevated after spatial training in the Morris water maze. The number of PSA-NCAM+ neuroblasts diminished by Aβ injection was completely restored by subsequent spatial learning. Spatial training leads to elevated expression of NLRP3 inflammasomes in the SGZ (subgranular zones): CD133+ and PSA-NCAM+ cells started to express NLRP3 in sham-operated, but not AD rats. Taken together, our data suggest that expression of NLRP3 inflammasomes in CD133+ and PSA-NCAM+ cells may contribute to stimulation of adult neurogenesis in physiological conditions, whereas Alzheimer's type neurodegeneration abolishes stimuli-induced overexpression of NLRP3 within the SGZ neurogenic niche.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.

Entities:  

Keywords:  Alzheimer’s disease; NLRP3 inflammasome; Neurogenesis; Neuroinflammation; Spatial learning

Mesh:

Substances:

Year:  2021        PMID: 33392919     DOI: 10.1007/s10571-020-01021-y

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  48 in total

Review 1.  The neural stem cell niche.

Authors:  Joanne C Conover; Ryan Q Notti
Journal:  Cell Tissue Res       Date:  2007-10-06       Impact factor: 5.249

2.  Silymarin and silymarin nanoparticles guard against chronic unpredictable mild stress induced depressive-like behavior in mice: involvement of neurogenesis and NLRP3 inflammasome.

Authors:  Aya Ashraf; Passant A Mahmoud; Haidy Reda; Salma Mansour; Mehad H Helal; Haidy E Michel; Maha Nasr
Journal:  J Psychopharmacol       Date:  2019-03-21       Impact factor: 4.153

Review 3.  Neural stem cell therapy for neurovascular injury in Alzheimer's disease.

Authors:  Austin C Boese; Milton H Hamblin; Jean-Pyo Lee
Journal:  Exp Neurol       Date:  2019-11-12       Impact factor: 5.330

4.  Brain inflammation induces post-synaptic changes during early synapse formation in adult-born hippocampal neurons.

Authors:  Deepti Chugh; Per Nilsson; Seyedeh-Atiyeh Afjei; Anahita Bakochi; Christine T Ekdahl
Journal:  Exp Neurol       Date:  2013-09-15       Impact factor: 5.330

5.  The effect of intrahippocampal beta amyloid (1-42) peptide injection on oxidant and antioxidant status in rat brain.

Authors:  Ferihan Cetin; Sibel Dincer
Journal:  Ann N Y Acad Sci       Date:  2007-04       Impact factor: 5.691

Review 6.  The role of adult neurogenesis in psychiatric and cognitive disorders.

Authors:  Deana M Apple; Rene Solano Fonseca; Erzsebet Kokovay
Journal:  Brain Res       Date:  2016-01-19       Impact factor: 3.252

7.  Strength Training Decreases Inflammation and Increases Cognition and Physical Fitness in Older Women with Cognitive Impairment.

Authors:  Matheus U Chupel; Fábio Direito; Guilherme E Furtado; Luciéle G Minuzzi; Filipa M Pedrosa; Juan C Colado; José P Ferreira; Edith Filaire; Ana M Teixeira
Journal:  Front Physiol       Date:  2017-06-12       Impact factor: 4.566

Review 8.  Targeting Neuroinflammation to Treat Alzheimer's Disease.

Authors:  A Ardura-Fabregat; E W G M Boddeke; A Boza-Serrano; S Brioschi; S Castro-Gomez; K Ceyzériat; C Dansokho; T Dierkes; G Gelders; Michael T Heneka; L Hoeijmakers; A Hoffmann; L Iaccarino; S Jahnert; K Kuhbandner; G Landreth; N Lonnemann; P A Löschmann; R M McManus; A Paulus; K Reemst; J M Sanchez-Caro; A Tiberi; A Van der Perren; A Vautheny; C Venegas; A Webers; P Weydt; T S Wijasa; X Xiang; Y Yang
Journal:  CNS Drugs       Date:  2017-12       Impact factor: 5.749

9.  Dual roles of Aβ in proliferative processes in an amyloidogenic model of Alzheimer's disease.

Authors:  David Baglietto-Vargas; Elisabeth Sánchez-Mejias; Victoria Navarro; Sebastián Jimenez; Laura Trujillo-Estrada; Angela Gómez-Arboledas; Maria Sánchez-Mico; Raquel Sánchez-Varo; Marisa Vizuete; José Carlos Dávila; José Manuel García-Verdugo; Javier Vitorica; Antonia Gutierrez
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

Review 10.  Surgery, neuroinflammation and cognitive impairment.

Authors:  Azeem Alam; Zac Hana; Zhaosheng Jin; Ka Chun Suen; Daqing Ma
Journal:  EBioMedicine       Date:  2018-10-19       Impact factor: 8.143

View more
  2 in total

Review 1.  Blood-Brain Barrier and Neurovascular Unit In Vitro Models for Studying Mitochondria-Driven Molecular Mechanisms of Neurodegeneration.

Authors:  Alla B Salmina; Ekaterina V Kharitonova; Yana V Gorina; Elena A Teplyashina; Natalia A Malinovskaya; Elena D Khilazheva; Angelina I Mosyagina; Andrey V Morgun; Anton N Shuvaev; Vladimir V Salmin; Olga L Lopatina; Yulia K Komleva
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

2.  NLRP3 Inflammasome Blocking as a Potential Treatment of Central Insulin Resistance in Early-Stage Alzheimer's Disease.

Authors:  Yulia K Komleva; Ilia V Potapenko; Olga L Lopatina; Yana V Gorina; Anatoly Chernykh; Elena D Khilazheva; Alla B Salmina; Anton N Shuvaev
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.